| Dr Jonathan Wayne Williams, MD | |
|
312 S Ave D, Burkburnett, TX 76354-3564 | |
| (940) 569-1177 | |
| (940) 569-4969 |
| Full Name | Dr Jonathan Wayne Williams |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 312 S Ave D, Burkburnett, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588621874 | NPI | - | NPPES |
| 110740105 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | K8574 (Texas) | Primary |
| 207Q00000X | Family Medicine | 20416 (Oklahoma) | Secondary |
| Entity Name | Grayson County Health Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891122198 PECOS PAC ID: 9638307648 Enrollment ID: O20140122000150 |
News Archive
It's been known for more than a century that acetaminophen is an effective painkiller, but according to a new U of T study it could also be impeding error-detection in the brain.
The nerve cell-damaging plaque that builds up in the brain with Alzheimer's disease also builds up in the retinas of the eyes - and it shows up there earlier, leading to the prospect that noninvasive optical imaging of the eyes could lead to earlier diagnosis, intervention and monitoring of the disease, according to new research.
The research, presented at the European Society of Human Reproduction and Embryology annual conference, which ends today in Geneva, Switzerland, describes for the first time the use of an experimental technique that has made it possible to analyze the functioning of human sperm in contact with the cytoplasmic content of the eggs in vitro.
Millstone Medical Outsourcing announced today that the company will open a state-of-the-art, 5,400 square foot clean room at Millstone's headquarters in Fall River, MA. The new clean room, which brings Millstone's overall clean room space to 8,000 plus square feet in total, will be operational by the end of next month.
In a first-time disclosure of IPN60090, a small-molecule inhibitor of the metabolic enzyme glutaminase (GLS1), researchers from The University of Texas MD Anderson Cancer Center's Therapeutics Discovery division and Ipsen Biopharmaceuticals reported the preclinical discovery and early-stage clinical development of this novel drug. IPN60090, now under investigation in a Phase I trial, may hold benefit for certain patients with lung and ovarian cancers.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonathan Wayne Williams, MD 1301 Third Street, Wichita Falls, TX 76301-2245 Ph: (940) 767-5145 | Dr Jonathan Wayne Williams, MD 312 S Ave D, Burkburnett, TX 76354-3564 Ph: (940) 569-1177 |
News Archive
It's been known for more than a century that acetaminophen is an effective painkiller, but according to a new U of T study it could also be impeding error-detection in the brain.
The nerve cell-damaging plaque that builds up in the brain with Alzheimer's disease also builds up in the retinas of the eyes - and it shows up there earlier, leading to the prospect that noninvasive optical imaging of the eyes could lead to earlier diagnosis, intervention and monitoring of the disease, according to new research.
The research, presented at the European Society of Human Reproduction and Embryology annual conference, which ends today in Geneva, Switzerland, describes for the first time the use of an experimental technique that has made it possible to analyze the functioning of human sperm in contact with the cytoplasmic content of the eggs in vitro.
Millstone Medical Outsourcing announced today that the company will open a state-of-the-art, 5,400 square foot clean room at Millstone's headquarters in Fall River, MA. The new clean room, which brings Millstone's overall clean room space to 8,000 plus square feet in total, will be operational by the end of next month.
In a first-time disclosure of IPN60090, a small-molecule inhibitor of the metabolic enzyme glutaminase (GLS1), researchers from The University of Texas MD Anderson Cancer Center's Therapeutics Discovery division and Ipsen Biopharmaceuticals reported the preclinical discovery and early-stage clinical development of this novel drug. IPN60090, now under investigation in a Phase I trial, may hold benefit for certain patients with lung and ovarian cancers.
› Verified 2 days ago
Dr. Jerome Mark Adams, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 501 E 3rd St, Burkburnett, TX 76354 Phone: 940-569-3351 Fax: 940-569-3353 | |
Rosa A Torres, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 600 S Red River Expy, Burkburnett, TX 76354 Phone: 940-569-2233 Fax: 940-569-0200 | |
Oscar C Torres, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 600 S Red River Expy, Burkburnett, TX 76354 Phone: 940-569-2233 Fax: 940-569-0200 |